Literature DB >> 3096998

Transcription initiation at the Escherichia coli galactose operon promoters in the absence of the normal -35 region sequences.

S Ponnambalam, C Webster, A Bingham, S Busby.   

Abstract

The gal operon regulatory region contains two overlapping promoters, P1 and P2, regulated by cyclic AMP and the cyclic AMP receptor protein (cAMP X CRP). Starting with a mutation that eliminated P1, the promoter that is usually dependent on cAMP X CRP, we constructed a series of deletions that substituted increasing amounts of DNA sequence from upstream of P2, the promoter that usually functions in the absence of cAMP X CRP. Expression from P2 in vivo was halved by deletions that replace the -35 region with unrelated sequences, showing that the -35 sequence participates in promoter function, but is not essential. In vitro studies show that replacement of the -35 sequence increases the time for open complex formation at P2, but does not alter the transcription start point. We examined the effects of the same deletions at the wild type gal promoter region: again, the deletion that replaces the -35 region halves expression in vivo. However, in this case, in the absence of cAMP X CRP, the deletion switches expression from the P2 promoter to P1, the promoter that is usually dependent on cAMP X CRP. Moreover, although the deletion also removes the specific cAMP X CRP binding site, this P1 activity is sharply inhibited in a crp+ background. We argue that this is due to a direct contact between CRP and RNA polymerase bound at the P1 Pribnow box, and we discuss the role of the -35 sequence at these and other promoters.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096998

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Characterization of the promoter elements for the staphylococcal enterotoxin D gene.

Authors:  S Zhang; G C Stewart
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

2.  Phi29 family of phages.

Authors:  W J Meijer; J A Horcajadas; M Salas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  The left end of IS2: a compromise between transpositional activity and an essential promoter function that regulates the transposition pathway.

Authors:  Leslie A Lewis; Edruge Cylin; Ho Kyung Lee; Robert Saby; Wilson Wong; Nigel D F Grindley
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

4.  Sequence elements in the Escherichia coli araFGH promoter.

Authors:  W Hendrickson; C Flaherty; L Molz
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

5.  The strong efficiency of the Escherichia coli gapA P1 promoter depends on a complex combination of functional determinants.

Authors:  Benoit Thouvenot; Bruno Charpentier; Christiane Branlant
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

6.  Reduced capacity of alternative sigmas to melt promoters ensures stringent promoter recognition.

Authors:  Byoung-Mo Koo; Virgil A Rhodius; Gen Nonaka; Pieter L deHaseth; Carol A Gross
Journal:  Genes Dev       Date:  2009-10-15       Impact factor: 11.361

7.  Different thermal energy requirement for open complex formation by Escherichia coli RNA polymerase at two related promoters.

Authors:  E Grimes; S Busby; S Minchin
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

8.  The Escherichia coli cysG promoter belongs to the 'extended -10' class of bacterial promoters.

Authors:  T Belyaeva; L Griffiths; S Minchin; J Cole; S Busby
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

9.  Redefining Escherichia coli σ(70) promoter elements: -15 motif as a complement of the -10 motif.

Authors:  Marko Djordjevic
Journal:  J Bacteriol       Date:  2011-09-09       Impact factor: 3.490

10.  Mutational analysis of the lac regulatory region: second-site changes that activate mutant promoters.

Authors:  R K Rothmel; J E LeClerc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.